Previous 10 | Next 10 |
home / stock / cphrf / cphrf news
Cipher Pharmaceuticals Inc. (CPHRF) Q2 2021 Earnings Conference Call August 13, 2021, 08:30 AM ET Company Participants Craig Mull - Interim CEO Scott Langille - CFO Conference Call Participants Doug Loe - Leede Jones Gable Presentation Operator Good morning, ladies and gentlemen. Thank you fo...
Cipher Pharmaceuticals Schedules Q2 2021 Earnings Release and Conference Call Canada NewsWire OAKVILLE, ON , Aug. 9, 2021 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or "the Company ") today announced it will release its Q2 2021 financial r...
Cipher Pharmaceuticals, Inc. (CPHRF) Q1 2021 Results Earnings Conference Call May 14, 2021, 08:00 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Scott Langille - Chief Financial Officer Conference Call Participants Douglas Loe - Leede Jones Gable Inc. Presentation Ope...
Cipher Pharmaceuticals (CPHRF): Q1 Non-GAAP EPS of $0.10; GAAP EPS of $0.05 beats by $0.14.Revenue of $5.4M (-8.5% Y/Y) beats by $0.19M.Press Release For further details see: Cipher Pharmaceuticals EPS beats by $0.14, beats on revenue
Cipher Pharmaceuticals Reports First Quarter 2021 Financial Results Canada NewsWire Generates Adjusted EBITDA of $3.6 million and EPS of $0.05 ( CDN$0.6 1 ) Excluding legal provision EPS was $0.10 (CDN$0.12) OAKVILLE, ON , ...
Cipher Pharmaceuticals Schedules Q1 2021 Earnings Release and Conference Call Canada NewsWire OAKVILLE, ON , May 5, 2021 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) (" Cipher " or "the Company ") today announced it will release its Q1 2021 ...
Cipher Pharmaceuticals ([[CPHRF]] -4.0%) announces that it has received approval from the Toronto Stock Exchange to amend its normal course issuer bid ((NCIB)) in order to enter into an automatic repurchase plan with its designated broker.The automatic repurchase plan enables Cipher to p...
Cipher Pharmaceuticals, Inc. (CPHRF) Q4 2020 Results Conference Call March 19, 2021 8:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Scott Langille - Chief Financial Officer Conference Call Participants Doug Loe - Leede Jones Gable Presentation Operator Good mornin...
Cipher Pharmaceuticals (CPHRF): Q4 Non-GAAP EPS of $0.19; GAAP EPS of $0.00 misses by $0.07.Revenue of $6.1M (+3.4% Y/Y) beats by $1.36M.Press Release For further details see: Cipher Pharmaceuticals EPS misses by $0.07, beats on revenue
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results Canada NewsWire Adjusted EBITDA increases 9% to $13.7 million and EPS increases 60% to $0.16 ( CDN$0.21 1 ) for the full year OAKVILLE, ...
News, Short Squeeze, Breakout and More Instantly...
Companhia Siderurgica Paulista Nova Cosipa Company Name:
CPHRF Stock Symbol:
OTCMKTS Market:
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders Canada NewsWire MISSISSAUGA, ON , June 14, 2024 /CNW/ - Cipher Pharmaceuticals Inc . (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the "Company ") today announced that i...
Cipher Pharmaceuticals Reports First Quarter 2024 Results Canada NewsWire (All figures are presented in U.S. Dollars) Adjusted EBITDA in Q1 2024 was $3.6 million , an increase of 12.5% over Q1 2023 Epuris sales volumes grew 7.2% in the quarter over Q1 2023, c...
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , May 3, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release ...